Phase I–II study of the farnesyl transferase inhibitor tipifarnib plus sequential weekly paclitaxel and doxorubicin–cyclophosphamide in HER2/neu-negative inflammatory carcinoma and non-inflammatory estrogen receptor-positive breast carcinoma

✍ Scribed by Andreopoulou, Eleni; Vigoda, Ivette S.; Valero, Vicente; Hershman, Dawn L.; Raptis, George; Vahdat, Linda T.; Han, Hyo S.; Wright, John J.; Pellegrino, Christine M.; Cristofanilli, Massimo; Alvarez, Ricardo H.; Fehn, Karen; Fineberg, Susan; Sparano, Joseph A.

• Book ID: 121613340
• Publisher: Springer US
• Year: 2013
• Tongue: English
• Weight: 216 KB
• Volume: 141
• Category: Article
• ISSN: 0167-6806
• DOI: 10.1007/s10549-013-2704-x